127 related articles for article (PubMed ID: 19150311)
1. International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure.
Arjal R; Trotter JF
Clin Liver Dis; 2009 Feb; 13(1):67-71. PubMed ID: 19150311
[TBL] [Abstract][Full Text] [Related]
2. The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure.
Kamath PS; Kim WR
Clin Liver Dis; 2009 Feb; 13(1):63-66. PubMed ID: 19150310
[TBL] [Abstract][Full Text] [Related]
3. [The value of MELD in the allocation of priority for liver transplantation candidates].
Colmenero J; Castro-Narro G; Navasa M
Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
[TBL] [Abstract][Full Text] [Related]
4. Application of a continuous disease severity score to the OPTN liver waiting list.
Edwards EB; Harper AM
Clin Transpl; 2001; ():19-24. PubMed ID: 12211782
[TBL] [Abstract][Full Text] [Related]
5. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
Trotter JF; Osgood MJ
JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
[TBL] [Abstract][Full Text] [Related]
6. The influence of laboratory-induced MELD score differences on liver allocation: more reality than myth.
Schouten JN; Francque S; Van Vlierberghe H; Colle I; Nevens F; Delwaide J; Adler M; Starkel P; Ysebaert D; Gadisseur A; De Winter B; Smits JM; Rahmel A; Michielsen P
Clin Transplant; 2012; 26(1):E62-70. PubMed ID: 22032173
[TBL] [Abstract][Full Text] [Related]
7. Model for end-stage liver disease (MELD) and allocation of donor livers.
Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
[TBL] [Abstract][Full Text] [Related]
8. Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area.
Xiol X; Gines P; Castells L; Twose J; Ribalta A; Fuentes-Arderiu X; Rodriguez S; Castellote J; Navasa M; Deulofeu R
Liver Transpl; 2009 Mar; 15(3):300-5. PubMed ID: 19242993
[TBL] [Abstract][Full Text] [Related]
9. Use of a pediatric end-stage liver disease score for deceased donor allocation: the United States experience.
McDiarmid SV; Merion RM; Dykstra DM; Harper AM
Indian J Pediatr; 2007 Apr; 74(4):387-92. PubMed ID: 17476086
[TBL] [Abstract][Full Text] [Related]
10. The international normalized ratio according to Owren in liver disease: interlaboratory assessment and determination of international sensitivity index.
Magnusson M; Sten-Linder M; Bergquist A; Rajani R; Kechagias S; Fischler B; Németh A; Lindahl TL
Thromb Res; 2013 Sep; 132(3):346-51. PubMed ID: 23993902
[TBL] [Abstract][Full Text] [Related]
11. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation.
Tripodi A; Chantarangkul V; Primignani M; Fabris F; Dell'Era A; Sei C; Mannucci PM
Hepatology; 2007 Aug; 46(2):520-7. PubMed ID: 17659574
[TBL] [Abstract][Full Text] [Related]
12. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
[TBL] [Abstract][Full Text] [Related]
13. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
[TBL] [Abstract][Full Text] [Related]
14. Re-weighting the model for end-stage liver disease score components.
Sharma P; Schaubel DE; Sima CS; Merion RM; Lok AS
Gastroenterology; 2008 Nov; 135(5):1575-81. PubMed ID: 18835388
[TBL] [Abstract][Full Text] [Related]
15. Selection of pediatric candidates under the PELD system.
McDiarmid SV; Merion RM; Dykstra DM; Harper AM
Liver Transpl; 2004 Oct; 10(10 Suppl 2):S23-30. PubMed ID: 15384170
[TBL] [Abstract][Full Text] [Related]
16. Does model for end-stage liver disease (MELD) require modification?
Desai HG
J Assoc Physicians India; 2011 Jun; 59():372-3. PubMed ID: 21751591
[TBL] [Abstract][Full Text] [Related]
17. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
Monteiro F; Coria SA; Boni R; Pereira LA
Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
[TBL] [Abstract][Full Text] [Related]
18. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
Shneider BL; Suchy FJ; Emre S
Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
[TBL] [Abstract][Full Text] [Related]
19. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology.
Bellest L; Eschwège V; Poupon R; Chazouillères O; Robert A
Hepatology; 2007 Aug; 46(2):528-34. PubMed ID: 17654598
[TBL] [Abstract][Full Text] [Related]
20. Predictors of death on the waiting list for liver transplantation characterized by a long waiting time.
Gheorghe L; Popescu I; Iacob R; Iacob S; Gheorghe C
Transpl Int; 2005 May; 18(5):572-6. PubMed ID: 15819806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
